These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4657532)

  • 1. [Legal basis and significance of manufacturing control in Switzerland].
    Fischer P
    Pharm Acta Helv; 1972; 47(11):629-36. PubMed ID: 4657532
    [No Abstract]   [Full Text] [Related]  

  • 2. 3. Drug regulations in Switzerland and their application.
    Hippenmeier F
    Bull Parenter Drug Assoc; 1974; 28(4):167-73. PubMed ID: 4855448
    [No Abstract]   [Full Text] [Related]  

  • 3. [Manufacturing and control in pharmaceutical industry. Introduction into manufacturing control. Introduction].
    Hippenmeier F
    Pharm Acta Helv; 1972; 47(11):625-8. PubMed ID: 4657531
    [No Abstract]   [Full Text] [Related]  

  • 4. [Practical realization of manufacturing control in Switzerland].
    Witschi T
    Pharm Acta Helv; 1972; 47(11):637-47. PubMed ID: 4657533
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical products and government policies.
    Fernandez ST
    Indian J Ophthalmol; 1988; 36(1):1-2. PubMed ID: 3253190
    [No Abstract]   [Full Text] [Related]  

  • 6. [Legal aspects of misuse of narcotics].
    Loeb B
    Schweiz Rundsch Med Prax; 1971 Apr; 60(16):495-6. PubMed ID: 5087746
    [No Abstract]   [Full Text] [Related]  

  • 7. [Quality control in herbal supplements].
    Oelker L
    Ann Ist Super Sanita; 2005; 41(1):43-8. PubMed ID: 16037649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remarks at the Food and Drug Law Institute's 48th Annual Conference.
    Niedelman SM
    Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089
    [No Abstract]   [Full Text] [Related]  

  • 9. [Standards imposed by the pharmacopoeia on drugs].
    Büchi J
    Pharm Acta Helv; 1972; 47(11):648-63. PubMed ID: 4657534
    [No Abstract]   [Full Text] [Related]  

  • 10. Multi-use manufacturing facilities.
    Garfinkle BD
    Dev Biol Stand; 1996; 88():131. PubMed ID: 9119124
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proposals for the legal control of the testing and introduction of drugs based on a comparison of drug laws in other countries].
    Burow W; Lüllmann H
    Schriftenr Geb Off Gesundheitswes; 1971; 31():1-64. PubMed ID: 5153578
    [No Abstract]   [Full Text] [Related]  

  • 12. Validation--how much can the world afford? Are we getting value for money?
    Anisfeld MH
    J Pharm Sci Technol; 1994; 48(1):45-8. PubMed ID: 8004419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Responsibility for drug testing and control].
    Büchi J
    Pharm Acta Helv; 1968 Sep; 43(9):619-27. PubMed ID: 5718866
    [No Abstract]   [Full Text] [Related]  

  • 14. [Physician and drug control].
    Wüst F
    Ther Umsch; 1971 Apr; 28(4):212-9. PubMed ID: 5575078
    [No Abstract]   [Full Text] [Related]  

  • 15. Parenteral manufacturing standards in Canada.
    Dunford RA
    Bull Parenter Drug Assoc; 1968; 22(5):209-14. PubMed ID: 5678806
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality control and good manufacturing practices: safety and efficacy of commercial herbals.
    Awang DV
    Food Drug Law J; 1997; 52(3):341-4. PubMed ID: 10343036
    [No Abstract]   [Full Text] [Related]  

  • 17. Separate manufacturing standards needed for veterinary drugs: AVMA.
    J Am Vet Med Assoc; 1996 Feb; 208(4):461. PubMed ID: 8603886
    [No Abstract]   [Full Text] [Related]  

  • 18. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 19. [Problems of guarantee control of drugs].
    Christoph KH
    Pharm Prax; 1967; 10():285-8. PubMed ID: 5615142
    [No Abstract]   [Full Text] [Related]  

  • 20. IV. Recent medicine legislation in the United Kingdom and its effect on manufacturing practice.
    Fishburn AG
    Bull Parenter Drug Assoc; 1974; 28(4):174-80. PubMed ID: 4852607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.